Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis
- PMID: 23219170
- DOI: 10.1016/j.jaci.2012.10.022
Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis
Abstract
Background: The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control.
Objective: We sought to test the reliability, validity, and responsiveness of RCAT and to estimate a cut-point score and minimal important difference (MID).
Methods: A total of 402 patients 12 years of age and older with allergic or nonallergic rhinitis were enrolled in a noninterventional study. Patients completed the RCAT (6 items; score range, 6-30) and had Total Nasal Symptom Scores (TNSSs) measured at baseline and 2 weeks later. Physicians completed a global assessment of rhinitis symptom control (Physician's Global Assessment) and disease severity. Internal consistency, test-retest reliability, convergent validity, known-groups validity, and responsiveness were evaluated. The MID was determined by using distribution- and anchor-based methods. Content validity of the RCAT was assessed in individual interviews with a separate group of 58 adult patients.
Results: Internal consistency and test-retest reliability of RCAT scores were 0.77 and 0.78, respectively. Convergent validity correlation between RCAT and TNSS scores was 0.57, and that between RCAT and Physician's Global Assessment scores was 0.34. Mean RCAT scores differed significantly (P < .001) across patient groups, differing in TNSS (F = 72.7), Physician's Global Assessment score (F = 28.6), and disease severity (F = 34.1) in the hypothesized direction. Results suggested a cut-point score of 21 or less can be used to identify patients who are experiencing rhinitis symptom control problems. The preliminary estimate of the MID was 3 points. Patients found RCAT items comprehensive, easy to understand, and relevant.
Conclusion: The RCAT demonstrated adequate reliability, validity, and responsiveness and was deemed acceptable and appropriate by patients. This tool can facilitate the detection of rhinitis symptom control problems, and its brevity supports its usefulness in clinical care.
Copyright © 2012 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.
Similar articles
-
Psychometric validation of the rhinitis control assessment test: a brief patient-completed instrument for evaluating rhinitis symptom control.Ann Allergy Asthma Immunol. 2010 Feb;104(2):118-24. doi: 10.1016/j.anai.2009.11.063. Ann Allergy Asthma Immunol. 2010. PMID: 20306814
-
A comparison of the psychometric properties of the Mini-Rhinitis Quality of Life Questionnaire and the Rhinitis Control Assessment Test.Am J Rhinol Allergy. 2012 Mar-Apr;26(2):127-33. doi: 10.2500/ajra.2012.26.3744. Am J Rhinol Allergy. 2012. PMID: 22487290
-
Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy.Clin Ther. 2005 Aug;27(8):1278-94. doi: 10.1016/j.clinthera.2005.08.002. Clin Ther. 2005. PMID: 16199253
-
The rhinitis control assessment test: implications for the present and future.Curr Opin Allergy Clin Immunol. 2014 Feb;14(1):13-9. doi: 10.1097/ACI.0000000000000020. Curr Opin Allergy Clin Immunol. 2014. PMID: 24300418 Review.
-
Outcomes and patient-based hearing status in conductive hearing loss.Laryngoscope. 2001 Nov;111(11 Pt 2 Suppl 98):1-21. doi: 10.1002/lary.5541111401. Laryngoscope. 2001. PMID: 11802001 Review.
Cited by
-
Translation into Portuguese and validation of the Rhinitis Control Assessment Test (RCAT) questionnaire.Braz J Otorhinolaryngol. 2016 Nov-Dec;82(6):674-679. doi: 10.1016/j.bjorl.2015.12.011. Epub 2016 Apr 16. Braz J Otorhinolaryngol. 2016. PMID: 27117891 Free PMC article.
-
Determining the minimal important differences in the RQLQ score with grass and tree allergy immunotherapy versus placebo in adults with moderate-to-severe allergy.Allergy. 2022 Jun;77(6):1843-1851. doi: 10.1111/all.15207. Epub 2022 Jan 22. Allergy. 2022. PMID: 34986506 Free PMC article.
-
A practical guide to prescribing sublingual immunotherapy tablets in North America for pediatric allergic rhinoconjunctivitis: an injection-free allergy immunotherapy option.Front Pediatr. 2023 Oct 4;11:1244146. doi: 10.3389/fped.2023.1244146. eCollection 2023. Front Pediatr. 2023. PMID: 37859770 Free PMC article. Review.
-
Control of allergic rhinitis in four latin american countries: Rinola study.Front Allergy. 2022 Aug 24;3:980515. doi: 10.3389/falgy.2022.980515. eCollection 2022. Front Allergy. 2022. PMID: 36092279 Free PMC article.
-
Patient uptake and outcomes following pharmacist-initiated referrals to general practitioners for asthma review.NPJ Prim Care Respir Med. 2022 Nov 17;32(1):53. doi: 10.1038/s41533-022-00315-6. NPJ Prim Care Respir Med. 2022. PMID: 36384948 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources